Docetaxel-induced hand foot syndrome: "No dose is a safe dose"

被引：7

作者：

Jain, Ankit ^{[1
]}

Dubashi, Biswajit ^{[1
]}

机构：

[1] Jawaharlal Inst Post Grad Med Educ & Res, Dept Med Oncol, Pondicherry 6, India

来源：

JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS | 2012年 / 3卷 / 02期

关键词：

Acral erythema breast cancer; docetaxel; hand foot syndorme; palmo-plantar dysesthesia;

D O I：

10.4103/0976-500X.95534

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Docetaxel is an important chemotherapeutic agent used in the management of many solid tumors. The most important side effect of this drug is myelosupression. We report a case of carcinoma breast that developed severe hand-foot syndrome at 75 mg/m(2) doses of docetaxel. The exact mechanism of this side effect in not known. All the physicians using this drug must be aware of this side effect.

引用

页码：200 / 201

页数：2

共 5 条

[1] Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel [J].

Chu, CY ;

Yang, CH ;

Yang, CY ;

Hsiao, GH ;

Chiu, HC .

BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (04) :808-811

[2]

Farhat MH, 2008, ANN SAUDI MED, V28, P374

[3] CHEMOTHERAPY-INDUCED ACRAL ERYTHEMA: A CLINICAL AND HISTOPATHOLOGIC STUDY OF 44 CASES [J].

Hueso, L. ;

Sanmartin, O. ;

Nagore, E. ;

Botella-Estrada, R. ;

Requena, C. ;

Llombart, B. ;

Serra-Guillen, C. ;

Alfaro-Rubio, A. ;

Guillen, C. .

ACTAS DERMO-SIFILIOGRAFICAS, 2008, 99 (04) :281-290

[4] Pyridoxine Is Not Effective to Prevent Hand-Foot Syndrome Associated With Capecitabine Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study [J].

Kang, Yoon-Koo ;

Lee, Sung Sook ;

Yoon, Dok Hyun ;

Lee, So Young ;

Chun, Young Ju ;

Kim, Min Sun ;

Ryu, Min-Hee ;

Chang, Heung-Moon ;

Lee, Jae-Lyun ;

Kim, Tae Won .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (24) :3824-3829

[5]

Kawaguchi K, 2011, BREAST CANC RES TREA, V130, P1641

← 1 →